Serum luteinizing hormone, follicle-stimulating hormone and oestradiol pattern in women undergoing pituitary suppression with different gonadotrophin-releasing hormone analogue protocols for assisted reproduction

References

• MacLachlan V, Besanko M, O'Shea F, Wade H, Wood C, Trounson A, Healy DL. A controlled study of luteinizing hormone-releasing hormone agonist (buserelin) for the induc-tion of folliculogenesis before in vitro fertilization. N Engl J Med 1989;320:1233–7.
   Google Scholar
• Filicori M. Clinical review: Gonadotropin-releasing hormone analogs in ovulation induction: current status and perspec-tives. J Clin Endocrinol Metab 1996;81:2413–16.
   PubMed Web of Science ®Google Scholar
• Hillier SG. Gonadotropic control of ovarian follicular growth and development. Mol Cell Endocrinol 2001;179:39–46.
   PubMed Web of Science ®Google Scholar
• Creus M, Penarrubia J, Fabregues F, Vidal E, Carmona F, Casamitjana R, Vanrell JA, Balasch J. Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum Reprod 2000;15:2341–6.
   PubMed Web of Science ®Google Scholar
• Filicori et al. (1999)
   Google Scholar
• Kilani Z, Dakkak A, Ghunaim S, Cognigni GE, Tabarelli C, Parmegiani L, Filicori M. A prospective, randomized, controlled trial comparing highly purified hMG with recom-binant FSH in women undergoing ICSI: ovarian response and clinical outcomes. Hum Reprod 2003;18:1194–9.
   Google Scholar
• Al Hasani S, Kupker W, Baschat AA, Sturm R, Bauer O, Diedrich C, Diedrich K. Mini-swim-up: a new technique of sperm preparation for intracytoplasmatic sperm injection. J Assist Reprod Genet 1995;12:428–33.
   Google Scholar
• Scott LA, Smith S. The successful use of pronuclear embryo transfers the day following oocyte retrieval. Hum Reprod 1998;13:1003–13.
   PubMed Web of Science ®Google Scholar
• Yim SF, Lok IH, Cheung LP, Briton-Jones CM, Chiu TT, Haines CJ. Dose-finding study for the use of long-acting gonadotrophin-releasing hormone analogues prior to ovarian stimulation for IVF. Hum Reprod 2001;16:492–4.
   Google Scholar
• Fleming R, Lloyd F, Herbert M, Fenwick J, Griffith T, Murdoch A. Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone. Hum Reprod 1998;13:1788–92.
   PubMed Web of Science ®Google Scholar
• Strohmer H, Chatwani S, Wieser F, Danninger B, Obruca A, Feichtinger W. Prospective randomized study of an ultrashort gonadotrophin-releasing hormone agonist versus a modified suppression protocol for ovarian stimulation in intracytoplas-mic sperm injection cycles. Hum Reprod 1997;12:1403–8.
   Google Scholar
• Janssens R1\4, Vermeiden JP, Lambalk CB, Schats R, Schoe-maker J. Gonadotrophin-releasing hormone agonist dose-dependency of pituitary desensitization during controlled ovarian hyperstimulation in IVF. Hum Reprod 1998;13:2386–91.
   Google Scholar
• Daya S. Gonadotropin releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles. Cochrane Database Syst Rev 2000; (2) : CD001299.
   Google Scholar
• Loumaye E, Van Krieken B, Depreester S, Psalti I, De Cooman S, Thomas K. Hormonal changes induced by short term administration of a gonadotrophin-releasing hormone agonist during ovarian hyperstimulation for in vitro fertiliza-tion and their consequences for embryo development. Fertil Steril 1989;51:105–11.
   PubMed Web of Science ®Google Scholar
• Tan SL, Kingsland C, Campbell S, Mills C, Bradfield J, Alexander N, Yovich J, Jacobs HS. The long protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization. Fertil Steril 1992;57:810–14.
   PubMedGoogle Scholar
• Stanger JD, Yovich JL. Reduced in-vitro fertilization of human oocyte from patients with raised basal luteinizing hormone levels during the follicular phase. Br J Obstet Gynaecol 1985;92:385–93.
   PubMedGoogle Scholar
• Howles CM, MacNamee MC, Edwards RG, Goswamy R, Steptoe PC. Effect of high tonic levels of luteinising hormone on outcome of in-vitro fertilisation. Lancet 1986;i:521–2.
   Google Scholar
• Chappel SC, Howles C. Re-evaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process. Hum Reprod 1991;6:1206–12.
   PubMed Web of Science ®Google Scholar
• Regan L, Owen EJ, Jacobs HS. Hypersecretion of luteinising hormone, infertility, and miscarriage. Lancet 1990;336:1141–4.
   Google Scholar
• Homburg R, Annar NA, Eshel A, Adams J, Jacobs HS. Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. Br Med J 1988;297:1024–6.
   Google Scholar
• Tesarik J, Hazout A, Mendoza C. Luteinizing hormone affects uterine receptivity independently of ovarian function. Reprod Biomed Online 2003;7:59–64.
   Google Scholar
• Overes HW, de Leeuw R, Kloosterboer HJ. Regulation of aromatase activity in FSH-primed rat granulosa cells in vitro by follicle-stimulating hormone and various amounts of human chorionic gonadotrophin. Hum Reprod 1992;7:191–6.
   PubMed Web of Science ®Google Scholar
• Yong EL, Baird DT, Yates R, Reichert LE Jr, Hillier SG. Hormonal regulation of the growth and steroidogenic function of human granulosa cells. J Clin Endocrinol Metab 1992;74:842–9.
   PubMed Web of Science ®Google Scholar
• Hillier SG. Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Hum Reprod 1994;9:188–91.
   PubMed Web of Science ®Google Scholar
• Erickson GF, Magoffin DA, Dyer CA, Hofeditz C. The ovarian androgen producing cells: a review of structure—function relationships. Endocr Rev 1985;6:371–99.
   PubMed Web of Science ®Google Scholar
• Richards JS, Hickey GJ, Chen SA, Shively JE, Hall PF, Gaddy-Kurten D, Kurten R. Hormonal regulation of estradiol biosynthesis, aromatase activity, and aromatase mRNA in rat ovarian follicles and corpora lutea. Steroids 1987;50:393–409.
   Google Scholar
• Gordon UD, Harrison RF, Fawzy M, Hennelly B, Gordon AC. A randomized prospective assessor-blind evaluation of luteinizing hormone dosage and in vitro fertilization outcome. Fertil Steril 2001;75:324–31.
   Google Scholar
• Humaidan P, Bungum L, Bungum M, Andersen CY. Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation. Hum Reprod 2002;17:2016–21.
   PubMed Web of Science ®Google Scholar
• Westergaard LG, Laursen SB, Andersen CY. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction. Hum Reprod 2000;15:1003–8.
   Google Scholar
• Tesarik J, Mendoza C. Effects of exogenous LH administra-tion during ovarian stimulation of pituitary down-regulated young oocytes donors on oocyte yield and developmental competence. Hum Reprod 2002;17:3129–37.
   PubMed Web of Science ®Google Scholar
• Hillier SG. Ovarian stimulation with recombinant gonado-tropins: LH as an adjunct to FSH. In: Jacobs HS, editor. The new frontier in ovulation induction. Carnforth, UK: Parthe-non Publishing; 1993. pp 39–47.
   Google Scholar
• Esposito MA, Barnhart KT, Coutifaris C, Patrizio P. Role of periovulatory luteinizing hormone concentrations during assisted reproductive technology cycles stimulated exclusively with recombinant follicle-stimulating hormone. Fertil Steril 2001;75:519–24.
   PubMed Web of Science ®Google Scholar
• Jacobs RA, Oosterhuis J, Porter DG, Lobb DX, Yuzpc AA, Challis JR. Immunoreactive adrenocorticotrophin is present in the ovary and in particular the oocyte of several mammalian species. J Reprod Fertil 1991;91:285–91.
   Google Scholar
• Rabe T, Diedrich K, Eberhardt I, Kupker W. In vitro fertilization. In: Rabe T, Diedrich K, Runnebaum B, editors. Manual on assisted reproduction. Berlin: Springer-Verlag; 1997. p 297.
   Google Scholar